ARMISTICE CAPITAL, LLC - Q3 2020 holdings

$2.76 Billion is the total value of ARMISTICE CAPITAL, LLC's 101 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .

 Value Shares↓ Weighting
ExitPREDICTIVE ONCOLOGY INC$0-484,624
-100.0%
-0.04%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-522,700
-100.0%
-0.04%
MDGS ExitMEDIGUS LTDsponsored ads$0-1,285,715
-100.0%
-0.04%
YTRA ExitYATRA ONLINE INC$0-1,800,000
-100.0%
-0.05%
ITRM ExitITERUM THERAPEUTICS PLC$0-1,262,553
-100.0%
-0.07%
TMDI ExitTITAN MED INC$0-2,363,457
-100.0%
-0.09%
CRI ExitCARTERS INC$0-42,201
-100.0%
-0.15%
TTPH ExitTETRAPHASE PHARMACEUTICALS I$0-1,419,507
-100.0%
-0.16%
BKNG ExitBOOKING HOLDINGS INC$0-4,000
-100.0%
-0.28%
ZEN ExitZENDESK INC$0-100,000
-100.0%
-0.39%
ESTC ExitELASTIC N V$0-100,000
-100.0%
-0.40%
KSS ExitKOHLS CORP$0-735,302
-100.0%
-0.67%
AIMT ExitAIMMUNE THERAPEUTICS INC$0-924,000
-100.0%
-0.68%
ORLY ExitOREILLY AUTOMOTIVE INC$0-36,635
-100.0%
-0.68%
DPZ ExitDOMINOS PIZZA INC$0-42,295
-100.0%
-0.68%
KFY ExitKORN FERRY$0-712,000
-100.0%
-0.96%
FL ExitFOOT LOCKER INC$0-814,740
-100.0%
-1.04%
CMG ExitCHIPOTLE MEXICAN GRILL INC$0-24,000
-100.0%
-1.11%
BURL ExitBURLINGTON STORES INC$0-145,364
-100.0%
-1.26%
BBY ExitBEST BUY INC$0-331,919
-100.0%
-1.27%
ATR ExitAPTARGROUP INC$0-288,000
-100.0%
-1.42%
DG ExitDOLLAR GEN CORP NEW$0-185,421
-100.0%
-1.55%
DBX ExitDROPBOX INCcl a$0-1,624,000
-100.0%
-1.55%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2756666000.0 != 2756669000.0)

Export ARMISTICE CAPITAL, LLC's holdings